British drugmaker Shire Plc said on Monday it had received an "approvable letter" from U.S. regulators for SPD465, its experimental treatment for attention deficit hyperactivity disorder (ADHD) in adults.
Source: Reuters
Helping Parents Succeed
British drugmaker Shire Plc said on Monday it had received an "approvable letter" from U.S. regulators for SPD465, its experimental treatment for attention deficit hyperactivity disorder (ADHD) in adults.
Source: Reuters
